Evolus, Inc. (EOLS) Live Share Price, Invest From India

Evolus, Inc. Stock Performance

as on December 13, 2025 at 2:29 am IST

Day's Low
$6.84
Day's Price Range
$7.04
$7.04
2.84%
Downside
52 Week's Low
52 Week's High
$5.71
52-Week Price Range
$17.12
$7.04
18.89%
Downside
143.18%
Upside

Evolus, Inc. share price movements today

Previous Close: $6.91
Open: $6.90
Volume: 692.5K
Day's Low - High: $6.84 - $7.04
52 Week Low - High: $5.71 - $17.12

Evolus, Inc. Historical Returns

1 Month Return: -4.48 %
3 Month Return: -2.09 %
1 Year Return: -38.84 %
3 Year Return: -4.61 %
5 Year Return: + 78.68 %

Evolus, Inc. Stock Fundamentals & Key Indicators

Check Evolus, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$447.9M

EPS (TTM)

-0.388

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-18.77

Industry PE ratio

-0.35549019607843135

PEG Ratio

EBITDA

-31.4M

Revenue (TTM)

285.8M

Profit Margin

-20.49%

Return On Equity TTM

-18729.61%

Evolus, Inc. Stock Valuation

Track how Evolus, Inc. P/E has moved over time to understand its valuation trends.

Evolus, Inc. in the last 5 years

Overview
Trends

Lowest (-50.93x)

December 31, 2024

Today (-18.77x)

December 13, 2025

Industry (-0.36x)

December 13, 2025

Highest (-1.99x)

December 31, 2020

LowHigh

Today’s Price to Earnings Ratio: -18.77x

Evolus, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evolus, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Evolus, Inc.	BUY	$447.9M	78.68%	-18.77	-20.49%
United Therapeutics Corporation	BUY	$22.3B	NA	18.52	40.65%
Neurocrine Biosciences Inc.	BUY	$15.4B	69.38%	37.2	15.95%
Haleon Plc Spon Ads	BUY	$42.7B	NA	21.31	13.81%
Zoetis Inc.	BUY	$52.1B	-25.62%	19.88	28.21%

Stock Returns calculator for Evolus, Inc. Stock including INR - Dollar returns

The Evolus, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Evolus, Inc. investment value today

Current value as on today

₹67,900

Returns

₹32,100

(-32.1%)

Returns from Evolus, Inc. Stock

₹38,836 (-38.84%)

Dollar Returns*

₹6,736 (+6.74%)

Analyst Recommendation on Evolus, Inc. Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Evolus, Inc.. Average target price of $18.5

Evolus, Inc. Share Price Target

Get share price movements and forecasts by analysts on Evolus, Inc..

What analysts predicted

61.95%UPSIDE

Target Price

$18.5

Current Price

$7.04

Analyzed by

14 Analysts

Target

$18.50

Evolus, Inc. target price $18.5, a slight upside of 61.95% compared to current price of $7.04. According to 14 analysts rating.

Evolus, Inc. Stock’s Investor Sentiment and Interest

Search interest for Evolus, Inc. Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 13, 2025 to December 13, 2025

Change:-44% versus previous 30 day period

Evolus, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Total Revenue	49	50	60	59	66	61	78	68	69	68
Gross Profit	34	34	38	40	47	42	50	46	45	45
Operating Income	-15	-13	-8	-8	-7	-15	-2	-15	-10	-11
EBITDA	-13	-11	-3	-6	-5	-13	0	-12	-7	-9
Interest Expense	3	3	4	4	4	4	4	4	7	4
Depreciation	1	1	1	1	1	1	1	1	2	2
Income Before Tax	-18	-16	-11	-13	-11	-19	-6	-18	-17	-15
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-18	-16	-11	-13	-11	-19	-6	-18	-17	-15
Net Profit Margin	-36.76%	-33.83%	-19.40%	-22.09%	-16.96%	-31.38%	-8.60%	-27.57%	-24.70%	-22.82%

Evolus, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	34	56	99	148	202	266
Gross Profit	0	0	0	-	26	38	56	89	140	182
Operating Income	-30	-19	-11	-46	-98	-153	-44	-65	-49	-34
EBITDA	-30	-19	-11	-45	-92	-144	-39	-53	-41	-25
Interest Expense	-	-	-	0	7	10	1	9	13	18
Depreciation	-	-	0	0	5	7	6	4	5	6
Income Before Tax	-31	-19	-11	-46	-105	-162	-46	-74	-61	-49
Income Tax Expense	0	0	-7	0	-15	0	0	0	0	0
Net Income	-31	-20	-4	-46	-90	-163	-46	-74	-61	-50
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-257.79%	-288.31%	-46.96%	-50.07%	-30.52%	-18.94%

Evolus, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	-16	-11	-13	-11	-19	-6	-18	-17	-15
Operating Cash Flow	0	0	-10	-6	-5	4	-15	-24	-14
Investing Cash Flow	0	0	0	-1	-1	-1	-1	-2	-2
Financing Cash Flow	-1	23	45	4	-1	-1	-1	20	-1
Change in Cash	-3	24	34	-3	-8	1	-19	-6	-18

Evolus, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-20	-4	-46	-90	-163	-46	-74	-61	-50
Operating Cash Flow	-13	-13	-25	-93	-57	-33	-84	-34	-17
Investing Cash Flow	0	0	0	-23	12	4	-2	-1	-4
Financing Cash Flow	13	13	118	133	38	73	-4	44	47
Change in Cash	0	0	93	16	-7	43	-92	8	24

Global Institutional Holdings in Evolus, Inc.

Funds	Holdings
Altium Capital Management, LP	0.46%

Insights on Evolus, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -18.89M → -15.73M (in $), with an average increase of 9.6% per quarter
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 78.7% return, outperforming this stock by 83.3%
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 36.5% return, outperforming this stock by 75.3%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 69.38M → 68.96M (in $), with an average decrease of 0.6% per quarter
NEGATIVE IMPACT
Price Dip
In the last 6 months, EOLS stock has moved down by -29.1%

About Evolus, Inc.

evolus, inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the united states. it offers jeuveau, a proprietary 900 kilodalton purified botulinum toxin type a formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. the company was founded in 2012 and is headquartered in newport beach, california.

Organisation	Evolus, Inc.
Headquarters	520 Newport Center Drive, Newport Beach, CA, United States, 92660
Industry	Health Technology
CEO	Mr. David Moatazedi
E-voting on shares	Click here to vote

Key Management of Evolus, Inc.

Name	Title
Mr. Nareg Sagherian	Head of Global Investor Relations & Corporate Communications
Mr. Jeffrey J. Plumer	General Counsel
Mr. Kurt Knab	Senior Vice President of Sales
Ms. Jessica Novak	Senior Vice President of Human Resources
Mr. David Moatazedi	President, CEO & Director
Ms. Tomoko Yamagishi-Dressler	Chief Marketing Officer
Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.	Chief Medical Officer and Head of Research & Development
Ms. Tatjana Mitchell	Chief Financial Officer

FAQs

What is Evolus, Inc. share price today?

Evolus, Inc. share price today is $7.04 as on December 13, 2025 at 2:29 am IST at the close of the market. Evolus, Inc. share today touched a day high of $7.04 and a low of $6.84.

What is the 52 week high and 52 week low for Evolus, Inc. share?

Evolus, Inc. share touched a 52 week high of $17.12 on February 13, 2025 and a 52 week low of $5.71 on August 11, 2025. Evolus, Inc. stock price today i.e. December 13, 2025 at 2:29 am IST is closed at $7.04,which is 58.88% down from its 52 week high and 23.29% up from its 52 week low.

What is Evolus, Inc.'s market capitalisation today?

Evolus, Inc. market capitalisation is $0.00T as on December 13, 2025 at 2:29 am IST.

How to invest in Evolus, Inc. Stock (EOLS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Evolus, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Evolus, Inc. Shares that will get you 0.2131 shares as per Evolus, Inc. share price of $7.04 per share as on December 13, 2025 at 2:29 am IST.

What is the minimum amount required to buy Evolus, Inc. Stock (EOLS) from India?

Indian investors can start investing in Evolus, Inc. (EOLS) shares with as little as ₹90.544 or $1 (as of December 13, 2025 at 11:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹905.44 in Evolus, Inc. stock (as per the Rupee-Dollar exchange rate as on December 13, 2025 at 11:42 pm IST). Based on Evolus, Inc. share’s latest price of $7.04 as on December 13, 2025 at 2:29 am IST, you will get 1.4205 shares of Evolus, Inc.. Learn more about fractional shares .

What are the returns that Evolus, Inc. has given to Indian investors in the last 5 years?

Evolus, Inc. stock has given 78.68% share price returns and 22.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?